Member Info for mulledwine

Brewin Dolphin upgraded Hyder Consulting (HYC) from "add" to "buy", with a 12 month target price of 476p, following recent price weakness. The broker believes that the engineering consultant has the best geographic exposure in the sector, with low EU exposure and more focus on Australian and the Middle East. Additionally, Brewin notes the group's increasing cash position, expected to be over 20 million pounds by March 2012, should facilitate future acquisitions. The broker adds that it would not be surprised to see the share price break 700p in two years time. Shares in Hyder rose 3p to 370p.

Rather a variation in broker targets !

Numis upgrades Enterprise Inns from hold to buy, target price 50p.

Nomura upgrades SABMiller to buy, target price raised from 2150p to 2400p.

The financial performance of ClearStream Technologies (CTN), is set to be comfortably in-line with market expectations, with revenues anticipated to show a significant increase over the previous year. The specialist medical devices supplier attributes the growth to increased sales of its products in new and existing markets, China being its strongest growth territory. This comes despite only one month’s contribution from the Intrepide range of stents, after its re-introduction to the market in July. The shares leapt 4.5p to 45p.

Hunting (HTG) has acquired precision machining company Dearborn Precision Tubular Products for 83.5 million dollars (51.2 million pounds). The target reported EBITDA of 7.8 million dollars (4.8 million pounds) for the six months ended 30th June 2011, and will be incorporated into energy services provider's oil and gas well construction business, adding to its range of products and services. Dearborn is expected to be earnings enhancing in its first full financial year following the acquisition.

http://www.investegate.co.uk/Article.aspx?id=201108150700093269M

In a move to focus on its core markets, RPC Group (RPC) has sold its Bramlage Verschlusse wines and spirits closures manufacturing business. The value of the gross assets was 2.9 million euros (2.55 million pounds), and the rigid plastic packaging manufacturer will use the funds to further its growth strategy in the German market. The subsidiary was sold to German bottle-cap maker Rauh, which has been working closely with the company for the last five years

http://www.investegate.co.uk/Article.aspx?id=201108150700113449M

Spectris (SXS) has bought control instrumentation manufacturer Omega Engineering for 475 million dollars (290 million pounds), as part of the engineering company's strategy to acquire stand-alone businesses with similar characteristics to its own. Spectris expects the target to be earning enhancing in the next financial year. Chief executive John O'Higgins said that the purchase will: "bring a significant strategic growth platform to our Industrial Controls segment."

http://www.investegate.co.uk/Article.aspx?id=201108150700113420M

Michael Page (MPI) reported pre-tax profits, before non-recurring items, of 45.5 million pounds for the six months ended 30th June, up 37.9% on last year's comparable period, but overall profits were down 26.5% at 30.5 million pounds. Additionally, Panmure Gordon expects the banking sector's recently announced job hiring freeze to weigh on profits in the second half of the financial year, as it previously accounted for 10% of the recruitment agency's revenues.

India based electricity company, OPG Power Ventures (OPG) remains a "buy" for Matrix, with a target price of 138p. Despite pre-tax profits coming in below forecasts, at 11.16 million pounds, against an expected 12.3 million pounds, the broker does not believe this justifies the near 40% fall in share price since its peak in January. Matrix notes that existing operations are running well with a plant load factor in the six months ended June at 88% and construction of the Chennai II project is on track to be completed in 2012

Cineworld (CINE) kept its "buy" rating from Panmure Gordon, with a target price of 260p, as the cinema industry remains resilient and year-to-date cinema admissions are up 0.7%. The broker comments on the stock being relatively inexpensive considering the company is in a strong position to grow earnings at compound annual growth rate of 11.5% over the next 3 years. Panmure adds that Cineworld's average ticket price remains the lowest of all majors which strengthens its market position.

http://www.investegate.co.uk/Article.aspx?id=201108150700083217M

Seymour Pierce reiterated its "buy" recommendation for Mitie (MTO) with a 300p target price. The broker reports that the outsourcing and energy services company has secured 85% of its revenues for the year and has demonstrated good organic growth across its markets. Seymour is also encouraged by the groups exposure to the building energy services market which is becoming the subject of increased interest in both the public and private sectors, as companies look to go green. Additionally, the broker notes that the shares are trading on an earnings multiple of 9.6 times, a significant discount to the peer group average of 11 times.

Evolution Securities has upgraded its rating for Wolseley (WOS) from "neutral" to "buy", with a target price of 2,200p. The broker notes that shares in the heating and plumbing company have fallen by a third since February 2011, which is a material under-performance relative to the market. The group's disposal of Build Centre and Brossette for 310 million pounds was over 100 million pounds more than the broker expected and alleviates it of two of its largest problem assets. Additionally, it will leave the balance sheet with low gearing, and allow Wolseley to being a new acquisition programme.

Panmure Gordon reiterated its "buy" recommendation for Dragon-Ukrainian Properties and Development (DUPD), with a 122p target price. Following the recent stock market volatility, the broker notes that with a forecasted full-year NAV of 169p, the shares are trading at a 72.1% discount. Panmure also says the company has a strong balance sheet with 38.4 million dollars (23.6 million pounds) of net cash as of 30th June and no debt

http://www.investegate.co.uk/Article.aspx?id=201108111200012012M

BTG (BGC) retained its "buy" rating from Daniel Stewart, with a target price of 337p. The broker believes the healthcare company has a well diversified portfolio, greatly reducing its risk. Additionally, with an forecasted cash reserve of 70 million pounds for the end of the year, Daniel Stewart notes the company's ability to further invest in product development or acquire new ones. The price was determined by a risk adjusted sum-of-parts analysis, which valued the company at 1.1 billion pounds.